Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||
| Net Income | -372 | -105 | 0 |
| Other Working Capital | 102 | -570 | 0 |
| Other Operating Activity | 64 | -3 | 0 |
| Operating Cash Flow | $-206 | $-678 | $0 |
| Cash Flows From Investing Activities | |||
| Other Investing Activity | 0 | -250,000 | 0 |
| Investing Cash Flow | $0 | $-250,000 | $0 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 0 | 252,013 | 0 |
| Financing Cash Flow | $0 | $252,013 | $0 |
| Beginning Cash Position | 1,335 | 0 | 0 |
| End Cash Position | 1,129 | 1,335 | 0 |
| Net Cash Flow | $-206 | $1,335 | $0 |
| Free Cash Flow | |||
| Operating Cash Flow | -206 | -678 | 0 |
| Free Cash Flow | -206 | -678 | 0 |